Table. Characteristics of serogroup W135 Neisseria meningitidis isolates from patients in France and Côte d'Ivoire, 2012.
Patient no. | Location† | Date of illness onset | Travel history | Date of return from travel | Patient age/sex | Test site |
N. meningitidis isolate test results |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sero | ST | CC | PorA VR1 | PorA VR2 | FetA | penA | |||||||
1 | France/ Paris region | Jan 14 | Benin | 2011 Dec 28 | 1 y/M | CSF | 2a | 11 | 11 | 5 | 2 | F1-1 | 1 |
2 | France/ Loire | Feb 15 | Senegal | Feb 12 | 62 y/F | Blood | 2a | 11 | 11 | 5 | 2 | F1-1 | 1 |
3 | France/ Rhône-Alpes | Feb 19 | Senegal | Feb 19 | 53 y/F | Blood | 2a | 11 | 11 | 5 | 2 | F1-1 | 1 |
4 | France/ Paris region | Feb 27 | Mali | Feb 23 | 4 y/M | AF | 2a | 11 | 11 | 5 | 2 | F1-1 | 1 |
5 | France/ Paris region | Mar 3 | Mali (family) | UNK | 5 y/F | CSF | 2a | 11 | 11 | 5 | 2 | F1-1 | 1 |
6 | France/ Paris region | Mar 6 | Senegal (father) | Feb 26 | 4 mo/F | CSF | 2a | 11 | 11 | 5 | 2 | F1-1 | 1 |
7 | Côte d'Ivoire/ Kouto | Feb 3 | UNK | NA | 12 y/M | CSF | 2a | 11 | 11 | 5 | 2 | F1-1 | 1 |
8 | Côte d'Ivoire/ Korhogo | Feb 3 | UNK | NA | 18 y/M | CSF | 2a | 11 | 11 | 5 | 2 | F1-1 | 1 |
9 | Côte d'Ivoire/ Kouto | Feb 23 | UNK | NA | 7 y/F | CSF | 2a | 11 | 11 | 5 | 2 | F1-1 | 1 |
10 | Côte d'Ivoire/ Kouto | Feb 24 | UNK | NA | 65 y/F | CSF | 2a | 11 | 11 | 5 | 2 | F1-1 | 1 |
11 | Côte d'Ivoire/ Kouto | Feb 24 | UNK | NA | 1 y/F | CSF | 2a | 11 | 11 | 5 | 2 | F1-1 | 1 |
12 | Côte d'Ivoire/ Tengrela | Feb 24 | UNK | NA | 19 y/F | CSF | 2a | 11 | 11 | 5 | 2 | F1-1 | 1 |
13 | Côte d'Ivoire/ Tengrela | Feb 24 | UNK | NA | 3 y/M | CSF | 2a | 11 | 11 | 5 | 2 | F1-1 | 1 |
14 | Côte d'Ivoire/ Tengrela | Feb 24 | UNK | NA | 5 y/M | CSF | 2a | 11 | 11 | 5 | 2 | F1-1 | 1 |
*All patients had meningitis except patients 2 and 3, who had bronchopneumonia and septicemia, and patient 4, who had arthritis. Sero, serotype; ST, sequence type, CC, clonal complex; VR, variable region; UNK, unknown; CSF, cerebrospinal fluid; AF, articular fluid; NA, not applicable. †Country/region where case was reported.